AMCR vs XFOR · P/E 18, rev $23.51B vs rev $4.8M
Amcor PLC (AMCR) versus X4 Pharmaceuticals Inc (XFOR) — a side-by-side from cached financials, not a winner call.
Amcor PLC (AMCR) is a packaging & containers company listed on US.
X4 Pharmaceuticals Inc (XFOR) is a biotechnology company listed on NASDAQ.
Latest reported AMCR revenue for 2026-06-30 was $23.51B. Net income was $1.11B. Revenue was up 362.5% from 2025-06-30 to 2026-06-30. AMCR currently screens at market cap $22.52B and trailing P/E 17.6.
Latest reported XFOR revenue for 2026-06-30 was $4.8M. Net income was -$36.4M. Revenue was up 92.0% from 2026-03-31 to 2026-06-30. XFOR currently screens at market cap $382.0M.
AMCR currently screens at market cap $22.52B and trailing P/E 17.6. XFOR currently screens at market cap $382.0M.
Not investment advice. Open the AMCR and XFOR stock pages for the full models.
Not investment advice.